Articles by Ragini Kudchadkar, MD
TIP113 HERTHENA-PanTumor01 (NCT06172478): Expansion of a Global Phase 2 Trial of HER3-DXd in Patients With Advanced/Metastatic HR+/HER2− Breast Cancer
ByFunda Meric-Bernstam, MD,Christos Fountzilas,Izuma Nakayama,Takahiro Kogawa,Tomohiro Nishina,Thomas Powles, MBBS, MCRP, MD,Jin Won Kim,Yen-Yang Chen,Francois Ghiringhelli,Valentina Gambardella,James W. Smithy,Jérome Fayette,Fan Jin,Y.K. Chang,Kendall Sullivan,Sue Yueh,Ajlan Atasoy,Andrea Sporchia,Ragini Kudchadkar, MD,Hidetoshi Hayashi 
The Absent-Minded Professor: An Unusual Complication of Melanoma
ByRagini Kudchadkar, MD,Rene Gonzalez, MD,William Robinson, MD, PhD,Maude Becker, RN,Krista Treichel, RN,Alan Kimura, MD,Karl Lewis, MD The University of Colorado Health Sciences Center holds weekly second opinion conferences focusing on cancer cases that represent most major cancer sites. Patients seen for second opinions are evaluated by an oncologist.
A Case of Merkel Cell Carcinoma
ByRagini Kudchadkar, MD,Rene Gonzalez, MD,Karl Lewis, MD,Krista Treichel, RN,William Robinson, MD, PhD,James Fitzpatrick, MD,Ricardo Gonzalez, MD,Brian Kavanagh, MD,Kyle Rusthoven, MD The University of Colorado Health Sciences Center holds weekly second opinion conferences focusing on cancer cases that represent most major cancer sites. Patients seen for second opinions are evaluated by an oncologist. Their history, pathology, and radiographs are reviewed during the multidisciplinary conference, and then specific recommendations are made. These cases are usually challenging, and these conferences provide an outstanding educational opportunity for staff, fellows, and residents in training.
